ArticleAlimentary pharmacology & therapeutics2020

Letter: online search trends suggest patient concerns around immunosuppression use in inflammatory bowel disease during COVID-19 in the United Kingdom.

Mohammed Nabil Quraishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.